Skip to content

Investigation of efficacy of ear piercings located at the crus of the helix in adults with migraine

Investigation of efficacy of ear piercings located at the crus of the helix in adults with migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00020553
Enrollment
60
Registered
2020-01-30
Start date
2020-02-06
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43

Interventions

Group 1: The participants keep a headache diary about their migraine attacks and fill in more comprehensive questionnaires immediately after study enrolment and then every two months until their pierc

Sponsors

Zentralinstitut für Seelische Gesundheit, Institut für Neuropsychologie und Klinische Psychologie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: - Subjects who have already decided in advance to have their ear pierced bilaterally through the crus of the helix - Diagnosis of migraine - No or stable migraine prophylaxis - Sufficient ability to answer questions orally and in writing - Sufficient ability to keep a headache diary - Written informed consent

Exclusion criteria

Exclusion criteria: - Revocation of consent - Getting further ear piercings during the study period - Other primary or secondary headache disease - Severe psychiatric, neurological and internal comorbidities - Pathology of the outer ear - Pregnancy - Drug abuse - Pharmacotherapy with psychoactive substances within the past 14 days

Design outcomes

Primary

MeasureTime frame
Using a headache diary the following data are collected and compared pre and post piercing intervention: Frequency, duration and intensity of migraine attacks

Secondary

MeasureTime frame
Using questionnaires the following psychometric data are collected and compared pre and post piercing intervention: - Headache-related disability (Migraine Disability Assessment) - Health-related quality of life (Veterans RAND 12 Item Health Survey) - Mood (Hospital Anxiety and Depression Scale) - Catastrophizing (Pain Catastrophizing Scale) - Subjective well-being (Marburg Questionnaire on Habitual Health Findings) - Drug use

Countries

Germany

Contacts

Public ContactHerta Flor

Zentralinstitut für Seelische Gesundheit, Institut für Neuropsychologie und Klinische Psychologie

migraenestudie@zi-mannheim.de0621 1703-6955

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026